LAB icon

Standard BioTools

72 hedge funds and large institutions have $138M invested in Standard BioTools in 2023 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 16 increasing their positions, 19 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding:

more ownership

Funds ownership:

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

16% less repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 19

16% less call options, than puts

Call options by funds: $83K | Put options by funds: $99K

Holders
72
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$83K
Puts
$99K
Net Calls
Net Calls Change

Top Sellers

1 -$3.18M
2 -$2.45M
3 -$2.35M
4
HighTower Advisors
HighTower Advisors
Illinois
-$1.72M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$577K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$22.1M
2
$21.6M
3
$13.2M
4
$12.9M
5
$11.5M
6
$8.94M
7
$7.82M
8
$5.18M
9
$3.96M
10
$3.55M
11
$3.5M
12
$3.48M
13
$2.84M
14
$2.2M
15
$1.78M
16
$1.45M
17
$1.37M
18
$1.24M
19
$870K
20
$811K
21
$615K
22
$587K
23
$559K
24
$550K
25
$419K